Modeling the Role of Parkinson’s Disease-Specific Factors in Depression and Anxiety: Findings from MEX-PD Cohort
Objective: This study, conducted within the Mexican Parkinson’s Disease Research Network (MEX-PD), aims to explore whether depression and anxiety in PD patients primarily stem from…Distinct pattern of synaptic loss in Parkinson’s disease depression and initial findings from the Yale Ketamine PD (KET-PD) trial
Objective: To investigate synaptic loss in Parkinson's Disease depression (PDd) using PET and [11C]UCB-J (a marker for synaptic density) and present the initial blinded findings…Suicide risk relationship with motor and non-motor symptoms in patients with Parkinson’s disease.
Objective: Determine Suicide Risk relationship with motor and non motor symptoms in patients with Parkinson´s disease. Background: Suicidal ideation is increased in people with Parkinson's…Efficacy of Audiovisual Neuromodulation in the Treatment of Parkinson’s Disease
Objective: To evaluate the AVS effectiveness in depression, anxiety, autonomic disorders and visual dysfunction in PD patients. Background: The severity of non-motor dopa-resistant symptoms in…Neurophysiological Underpinnings of Apathy in Parkinson’s Disease Versus Depressive Disorders: A Comparative Study
Objective: The manifestation of apathy in neurological and psychiatric conditions such as Parkinson's Disease (PD) and depressive disorders presents a significant clinical challenge. This study…Effect Of Botulinum Toxin On Non-Motor Symptoms In Adult-Onset Idiopathic Focal Dystonia
Objective: To assess the effect of Botulinum toxin on non-motor symptoms and quality of life in patients with adult-onset idiopathic focal dystonia. Background: A broad…Listening to the Insight: The Underdiagnosis of Depression in People Living with Parkinson’s Disease
Objective: To determine the prevalence of risk of undiagnosed depression among people living with Parkinson's disease (PwP) without a prior depression diagnosis. Background: Parkinson's disease…Clinical and Epidemiological Aspects of Neuropsychiatric Features in Patients with Huntington Disease in Chile
Objective: To describe the prevalence of motor and neuropsychiatric symptoms in HD patients seen at the Center of Movement Disorders (CETRAM), Santiago, Chile. Background: There…Neuropsychiatric symptoms in patients with probable Progressive supranuclear palsy in reference centers of Valle del Cauca- Colombia
Objective: To evaluate the neuropsychiatric symptoms in patients with probable Progressive supranuclear palsy attended in reference centers of the Valle del Cauca, Colombia, between 2020 and…Apathy in de novo Parkinson’s disease improves after the first years with dopaminergic treatment.
Objective: to define the evolution of apathy and other neuropsychiatric symptoms in patients with early Parkinson’s disease (PD). Background: Apathy is a common neuropsychiatric symptom…
- 1
- 2
- 3
- …
- 32
- Next Page »